Pharmaceutical

MSD’s Keytruda wins expanded FDA combo approval in cerv...

MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures ...

Basilea buys Spexis’ preclinical antibiotics programme ...

The acquired programme consists of antibiotics against gram-negative bacteria, i...

PCM Trials acquires Netherlands-based Clinical Trial Se...

PCM Trials, a Denver, USA based leader in providing mobile research nurses for d...

STAT+: For-profit biomedical institute, backed by billi...

Arena Bioworks has already lured top scientists from academic labs, raising some...

Opinion: What STAT readers think about JPM’s locked lac...

What STAT readers think about JPM's locked lactation room, covering weight loss ...

Santhera’s Agamree becomes first approved treatment in ...

The UK nod for Agamree, which comes after previous approvals in Europe and the U...

Dermavant maps out atopic dermatitis filing after posit...

Dermavant will include these findings in an upcoming supplemental new drug appli...

Ji Xing acquires Biogen’s BIIB131 for acute ischemic st...

Ji Xing Pharmaceuticals acquired Biogen’s BIIB131 for advancing worldwide clinic...

ClinChoice enhances global reach with CSI Medical acqui...

Contract research organisation ClinChoice has acquired CSI Medical Research, mar...

Cereno partners with CordenPharma to scale up CS1 drug ...

Cereno Scientific has announced a partnership with CordenPharma to scale up manu...

SyntheticGestalt and Enamine partner on AI drug discove...

SyntheticGestalt and Enamine have announced a collaboration to develop a suite o...

Q&A: Exploring the challenges behind oncology trials

Pauline Frank reflects on her talk at the 2023 CTO Europe conference and highlig...

FDA yet to find link between suicidal risk and GLP-1RA use

In an update, the FDA reported that it is yet to find a definitive association b...

Obesity disease management needs to be revolutionised

Obesity has only recently been recognised as a disease as opposed to a behaviour...

Emergent wins $235.8m US defence contract for Anthrax v...

The US Department of Defense procurement contract for Emergent’s BioThrax is com...

Novartis reportedly decides to pass on Cytokinetics

Want to stay on top of the science and politics driving biotech today? Sign up t...